On February 12, 2019 Alligator Bioscience reported that it will publish its report for the year ended 31 December 2018 (Press release, Alligator Bioscience, FEB 12, 2019, https://alligatorbioscience.se/en/alligator-bioscience-to-host-conference-call-to-provide-year-end-report-2018-business-update/ [SID1234538670]). All interested parties are invited to participate in a telephone conference, which will include a presentation of the Year-end Report, on the same day at 09:00 a.m. CET. The event will be hosted by CEO Per Norlén and the presentation will be held in English.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
When: 09:00 a.m. CET Thursday 14 February 2019
Listen to the presentation: View Source
To participate in the telephone conference, please use the dial in details shown below:
SE: +46856642692
UK: +443333009266
US: +18338230590
The conference call will be made available on the company’s website after the call: View Source
For further information, please contact:
Cecilia Hofvander, Director Investor Relations & Communications
Phone +46 46 540 82 06
E-mail: [email protected]